PGR
Basic information
Region (hg38): 11:101029624-101129813
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PGR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | |||||
missense | 40 | 46 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 40 | 7 | 13 |
Variants in PGR
This is a list of pathogenic ClinVar variants found in the PGR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-101039138-G-T | not specified | Uncertain significance (Sep 26, 2022) | ||
11-101041987-C-T | Benign (Jul 05, 2018) | |||
11-101051458-T-C | not specified | Uncertain significance (May 18, 2022) | ||
11-101062583-C-T | not specified | Uncertain significance (Apr 23, 2024) | ||
11-101062676-G-A | Benign (May 24, 2018) | |||
11-101062677-C-T | not specified | Uncertain significance (May 28, 2024) | ||
11-101062708-G-C | Benign (Aug 07, 2018) | |||
11-101091797-G-T | Benign (Aug 04, 2018) | |||
11-101125999-G-A | Benign (Aug 16, 2018) | |||
11-101126013-T-C | not specified | Uncertain significance (Aug 30, 2021) | ||
11-101126118-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
11-101126126-T-C | not specified | Uncertain significance (Mar 25, 2024) | ||
11-101127443-T-C | not specified | Uncertain significance (Feb 05, 2024) | ||
11-101127456-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
11-101127464-T-G | Benign (Nov 20, 2018) | |||
11-101127496-G-A | Likely benign (Apr 11, 2018) | |||
11-101127596-C-A | not specified | Uncertain significance (Feb 22, 2023) | ||
11-101127599-G-C | not specified | Uncertain significance (May 04, 2022) | ||
11-101127627-C-T | not specified | Uncertain significance (Dec 16, 2023) | ||
11-101127633-A-C | not specified | Uncertain significance (Aug 12, 2021) | ||
11-101127728-A-G | not specified | Uncertain significance (Nov 22, 2021) | ||
11-101127748-G-C | Likely benign (Jun 26, 2018) | |||
11-101127766-C-G | Likely benign (Jun 08, 2018) | |||
11-101127770-G-C | not specified | Uncertain significance (Jun 19, 2024) | ||
11-101127800-G-C | not specified | Uncertain significance (Dec 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PGR | protein_coding | protein_coding | ENST00000325455 | 8 | 100901 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0510 | 0.949 | 125731 | 0 | 17 | 125748 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.28 | 426 | 507 | 0.840 | 0.0000242 | 5880 |
Missense in Polyphen | 121 | 202.08 | 0.59878 | 2475 | ||
Synonymous | -0.435 | 224 | 216 | 1.04 | 0.0000106 | 1983 |
Loss of Function | 3.91 | 9 | 33.4 | 0.269 | 0.00000165 | 403 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000881 | 0.0000881 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000171 | 0.000163 |
Finnish | 0.0000963 | 0.0000924 |
European (Non-Finnish) | 0.0000534 | 0.0000527 |
Middle Eastern | 0.000171 | 0.000163 |
South Asian | 0.0000670 | 0.0000653 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Depending on the isoform, progesterone receptor functions as transcriptional activator or repressor. {ECO:0000269|PubMed:10757795, ECO:0000269|PubMed:1587864, ECO:0000269|PubMed:9407067, ECO:0000305}.; FUNCTION: Isoform B: Transcriptional activator of several progesteron-dependent promoters in a variety of cell types. Involved in activation of SRC-dependent MAPK signaling on hormone stimulation. {ECO:0000269|PubMed:7969170}.;
- Pathway
- Oocyte meiosis - Homo sapiens (human);Breast cancer - Homo sapiens (human);Estrogen signaling pathway - Homo sapiens (human);Progesterone-mediated oocyte maturation - Homo sapiens (human);NHR;Nuclear Receptors;Signaling by ERBB4;Ovarian Infertility Genes;Signal Transduction;Gene expression (Transcription);how progesterone initiates the oocyte maturation;Generic Transcription Pathway;HSP90 chaperone cycle for steroid hormone receptors (SHR);Cellular responses to stress;Nuclear Receptor transcription pathway;RNA Polymerase II Transcription;Cellular responses to external stimuli;Signaling by Nuclear Receptors;Estrogen-dependent gene expression;Nuclear signaling by ERBB4;Signaling by ERBB4;Signaling by Receptor Tyrosine Kinases;ESR-mediated signaling;Validated nuclear estrogen receptor alpha network;Cellular roles of Anthrax toxin
(Consensus)
Recessive Scores
- pRec
- 0.530
Haploinsufficiency Scores
- pHI
- 0.139
- hipred
- Y
- hipred_score
- 0.834
- ghis
- 0.398
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.499
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pgr
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; limbs/digits/tail phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); neoplasm; embryo phenotype;
Zebrafish Information Network
- Gene name
- pgr
- Affected structure
- oocyte stage V
- Phenotype tag
- abnormal
- Phenotype quality
- non-functional
Gene ontology
- Biological process
- ovulation from ovarian follicle;epithelial cell maturation;transcription initiation from RNA polymerase II promoter;signal transduction;cell-cell signaling;negative regulation of gene expression;paracrine signaling;positive regulation of transcription by RNA polymerase II;lung alveolus development;regulation of epithelial cell proliferation;progesterone receptor signaling pathway;tertiary branching involved in mammary gland duct morphogenesis
- Cellular component
- nucleoplasm;mitochondrial outer membrane;cytosol
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;steroid hormone receptor activity;nuclear receptor activity;steroid binding;protein binding;zinc ion binding;enzyme binding;identical protein binding;ATPase binding